Application of a scavenger receptor a1-targeted polymeric prodrug platform for lymphatic drug delivery in HIV

Stephan T. Stern, David M. Stevens, Pavan Adiseshaiah, Siva S.K. Dasa, Tim M. Potter, Sarah L. Skoczen, Kelsie S. Snapp, Edward Cedrone, Nimit Patel, Kathleen Busman-Sahay, Elias P. Rosen, Craig Sykes, MacKenzie Cottrell, Marina A. Dobrovolskaia, Jacob D. Estes, Angela D.M. Kashuba

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


We have developed a macromolecular prodrug platform based on poly(L-lysine succinylated) (PLS) that targets scavenger receptor A1 (SR-A1), a receptor expressed by myeloid and endothelial cells. We demonstrate the selective uptake of PLS by murine macrophage, RAW 264.7 cells, which was eliminated upon cotreatment with the SR-A inhibitor polyinosinic acid (poly I). Further, we observed no uptake of PLS in an SR-A1-deficient RAW 264.7 cell line, even after 24 h incubation. In mice, PLS distributed to lymphatic organs following i.v. injection, as observed by ex vivo fluorescent imaging, and accumulated in lymph nodes following both i.v. and i.d. administrations, based on immunohistochemical analysis with high-resolution microscopy. As a proof-ofconcept, the HIV antiviral emtricitabine (FTC) was conjugated to the polymer's succinyl groups via ester bonds, with a drug loading of 14.2% (wt/wt). The prodrug (PLS-FTC) demonstrated controlled release properties in vitro with a release half-life of 15 h in human plasma and 29 h in esterase-inhibited plasma, indicating that drug release occurs through both enzymatic and nonenzymatic mechanisms. Upon incubation of PLS-FTC with human peripheral blood mononuclear cells (PBMCs), the released drug was converted to the active metabolite FTC triphosphate. In a pharmacokinetic study in rats, the prodrug achieved ∼7-19-fold higher concentrations in lymphatic tissues compared to those in FTC control, supporting lymphatic-targeted drug delivery. We believe that the SR-A1-targeted macromolecular PLS prodrug platform has extraordinary potential for the treatment of infectious diseases.

Original languageEnglish (US)
Pages (from-to)3794-3812
Number of pages19
JournalMolecular Pharmaceutics
Issue number10
StatePublished - Oct 5 2020
Externally publishedYes


  • Emtricitabine
  • FTC
  • HIV
  • Lymphatic distribution
  • Macromolecular prodrug
  • Polymeric prodrug
  • Prodrug
  • Scavenger receptor A1 (SR-A1)

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery


Dive into the research topics of 'Application of a scavenger receptor a1-targeted polymeric prodrug platform for lymphatic drug delivery in HIV'. Together they form a unique fingerprint.

Cite this